Valerio Therapeutics (XPAR:ALVIO) Beginning Cash Position : €8.07 Mil (As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Valerio Therapeutics Beginning Cash Position?

Valerio Therapeutics's Beginning Cash Position for the quarter that ended in Dec. 2024 was €8.07 Mil.

Valerio Therapeutics's quarterly Beginning Cash Position declined from Dec. 2023 (€15.62 Mil) to Jun. 2024 (€6.81 Mil) but then increased from Jun. 2024 (€6.81 Mil) to Dec. 2024 (€8.07 Mil).

Valerio Therapeutics's annual Beginning Cash Position declined from Dec. 2022 (€17.89 Mil) to Dec. 2023 (€13.38 Mil) and declined from Dec. 2023 (€13.38 Mil) to Dec. 2024 (€10.91 Mil).

Valerio Therapeutics Beginning Cash Position Historical Data

The historical data trend for Valerio Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valerio Therapeutics Beginning Cash Position Chart

Valerio Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

5.71

14.52

17.89

13.38

10.91

Valerio Therapeutics Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Beginning Cash Position	Get a 7-Day Free Trial															26.86	14.59	15.62	6.81	8.07

Valerio Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Valerio Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Valerio Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Valerio Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valerio Therapeutics (XPAR:ALVIO) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

0NWK:UK C4X:Germany

Address

49 Boulevard du General, Martial Valin, Paris, FRA, 75015

Website

https://www.valeriotx.com

Valerio Therapeutics is a clinical-stage biotechnology company designing and developing novel oncology drugs targeting tumor DNA repair functions. Its therapeutic strategy focuses on fighting tumor resistance to treatments, which poses ever-greater therapeutic challenges, especially in aggressive or rare cancers. its approach is based upon unique mechanisms of action on DNA Damage Response. The company focuses on bringing first-in-class and disruptive compounds from preclinical research to proof-of-concept in man in cancer indications with high unmet needs.

Valerio Therapeutics Headlines

No Headlines